N. Sabbagh

发表

Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolution.

J. Lafitte, C. Spire, U. Meyer, 1997, Pharmacogenetics.

Evidence for CYP2D6 expression in human lung.

J. Lafitte, C. Spire, D. Marez, 1997, Biochemical and biophysical research communications.

An efficient strategy for detection of known and new mutations of the CYP2D6 gene using single strand conformation polymorphism analysis.

U. Meyer, S. Millecamps, D. Marez, 1995, Pharmacogenetics.

Influence of a mutation reducing the catalytic activity of the cytochrome P450 CYP2D6 on lung cancer susceptibility.

J. Lo-Guidice, D. Marez, M. Legrand, 1996, Carcinogenesis.

Cytochrome P450 CYP2D6 gene polymorphism and lung cancer susceptibility in Caucasians.

P. Beaune, J. Lafitte, C. Spire, 1998, Pharmacogenetics.

NAT2 genotyping and efficacy of sulfasalazine in patients with chronic discoid lupus erythematosus.

J. Lo-Guidice, D. Marez, N. Sabbagh, 1997, Pharmacogenetics.

A novel CYP2D6 allele with an abolished splice recognition site associated with the poor metabolizer phenotype.

J. Lo-Guidice, D. Marez, M. Legrand, 1995, Pharmacogenetics.

Characterization of a variable number tandem repeat region in the thiopurine S-methyltransferase gene promoter.

J. D'halluin, D. Marez, N. Sabbagh, 1999, Pharmacogenetics.

Detection of known and new mutations in the thiopurine S‐methyltransferase gene by single‐strand conformation polymorphism analysis

D. Marez, N. Sabbagh, F. Broly, 1998, Human mutation.

An additional allelic variant of the CYP2D6 gene causing impaired metabolism of sparteine

J. Lo-Guidice, D. Marez, M. Legrand, 1996, Human Genetics.

A nonsense mutation in the cytochrome P450 CYP2D6 gene identified in a Caucasian with an enzyme deficiency

U. Meyer, D. Marez, M. Legrand, 1995, Human Genetics.